{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:10:06Z","timestamp":1778764206945,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005297","name":"Uniwersytet Medyczny w Bialymstoku","doi-asserted-by":"publisher","award":["N\/ST\/MN\/17\/002\/2214"],"award-info":[{"award-number":["N\/ST\/MN\/17\/002\/2214"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005297","name":"Uniwersytet Medyczny w Bialymstoku","doi-asserted-by":"publisher","award":["POPW.01.03.00-20-008\/09"],"award-info":[{"award-number":["POPW.01.03.00-20-008\/09"]}],"id":[{"id":"10.13039\/501100005297","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007752","name":"Axis IT and T","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004906","name":"Pennsylvania Department of Environmental Protection","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004906","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Probes"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.mcp.2019.101488","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T11:41:10Z","timestamp":1573645270000},"page":"101488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Verapamil and collagenase differentially affect collagen metabolism in experimental model of Peyronie's disease"],"prefix":"10.1016","volume":"49","author":[{"given":"Jacek","family":"Karaszewski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7934-6973","authenticated-orcid":false,"given":"Ilona","family":"Zareba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8911-9643","authenticated-orcid":false,"given":"Tomasz","family":"Guszczyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8839-1290","authenticated-orcid":false,"given":"Barbara","family":"Darewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8476-2023","authenticated-orcid":false,"given":"Jerzy","family":"Palka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mcp.2019.101488_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0022-5347(01)65361-8","article-title":"Proposal: trauma as the cause of the Peyronie's lesion","volume":"157","author":"Devine","year":"1997","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.mcp.2019.101488_bib2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ncpuro0201","article-title":"Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease","volume":"6","author":"Gonzalez-Cadavid","year":"2005","journal-title":"Nat. Clin. Pract. Urol."},{"issue":"3","key":"10.1016\/j.mcp.2019.101488_bib3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1464-410X.2006.05969.x","article-title":"Risk factors for Peyronie's disease: a case-control study","volume":"97","author":"Bjekic","year":"2006","journal-title":"BJU Int."},{"issue":"7","key":"10.1016\/j.mcp.2019.101488_bib4","first-page":"2359","article-title":"The management of Peyronie's disease","volume":"7","author":"Ralph","year":"2010","journal-title":"evidence-based 2010 guidelines, J Sex Med"},{"issue":"5","key":"10.1016\/j.mcp.2019.101488_bib5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/sj.ijir.3900877","article-title":"Clinical presentations of Peyronie's disease","volume":"14","author":"Pryor","year":"2002","journal-title":"Int. J. Impot. Res."},{"issue":"6","key":"10.1016\/j.mcp.2019.101488_bib6","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0022-5347(17)39746-X","article-title":"The natural history of Peyronie's disease","volume":"144","author":"Gelbard","year":"1990","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.mcp.2019.101488_bib7","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","article-title":"An analysis of the natural history of Peyronie's disease","volume":"175","author":"Mulhall","year":"2006","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.mcp.2019.101488_bib8","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/sj.ijir.3900558","article-title":"Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents","author":"Anderson","year":"2000","journal-title":"Int J Impot Res 12"},{"issue":"5","key":"10.1016\/j.mcp.2019.101488_bib9","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.urology.2007.01.080","article-title":"Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease","volume":"69","author":"Cavallini","year":"2007","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.mcp.2019.101488_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.mcp.2019.101488_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/(SICI)1097-4644(19971101)67:2<166::AID-JCB2>3.0.CO;2-V","article-title":"Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors","volume":"67","author":"Palka","year":"1997","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.mcp.2019.101488_bib12","first-page":"19","article-title":"Determination of collagen synthesis in tissue and cell culture system","author":"Perekofsky","year":"1982","journal-title":"Immunochemistry of the extracellular matrix."},{"issue":"2","key":"10.1016\/j.mcp.2019.101488_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0009-8981(82)90196-6","article-title":"Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria","volume":"125","author":"Myara","year":"1982","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.mcp.2019.101488_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","author":"Lowry","year":"1951","journal-title":"J Biol Chem 193(1)"},{"issue":"2","key":"10.1016\/j.mcp.2019.101488_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1071\/SH05031","article-title":"A clinico-aetiological and ultrasonographic study of Peyronie's disease","volume":"3","author":"Kumar","year":"2006","journal-title":"Sex. Health"},{"key":"10.1016\/j.mcp.2019.101488_bib16","first-page":"2350","article-title":"Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening","author":"Mulhall","year":"2004","journal-title":"J Urol 171(6 Pt 1)"},{"issue":"2","key":"10.1016\/j.mcp.2019.101488_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ijir.3901518","article-title":"The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction","volume":"19","author":"Arafa","year":"2007","journal-title":"Int. J. Impot. Res."},{"issue":"3","key":"10.1016\/j.mcp.2019.101488_bib18","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0022-5347(05)64578-8","article-title":"A retrospective review of 307 men with Peyronie's disease","volume":"168","author":"Kadioglu","year":"2002","journal-title":"J. Urol."},{"issue":"4 Pt 1","key":"10.1016\/j.mcp.2019.101488_bib19","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1743-6109.2009.01584.x","article-title":"A cross-sectional study for the analysis of clinical, sexual and laboratory conditions associated to Peyronie's disease","volume":"7","author":"Rhoden","year":"2010","journal-title":"J. Sex. Med."},{"issue":"8","key":"10.1016\/j.mcp.2019.101488_bib20","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1111\/j.1743-6109.2008.00895.x","article-title":"The chronology of depression and distress in men with Peyronie's disease","volume":"5","author":"Nelson","year":"2008","journal-title":"J. Sex. Med."},{"issue":"6","key":"10.1016\/j.mcp.2019.101488_bib21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0895-4356(98)00015-8","article-title":"A case-control study on risk factors for Peyronie's disease","volume":"51","author":"Carrieri","year":"1998","journal-title":"J. Clin. Epidemiol."},{"issue":"2","key":"10.1016\/j.mcp.2019.101488_bib22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1743-6109.2006.00344.x","article-title":"Defining the clinical characteristics of Peyronie's disease in young men","volume":"4","author":"Deveci","year":"2007","journal-title":"J. Sex. Med."},{"issue":"3","key":"10.1016\/j.mcp.2019.101488_bib23","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1743-6109.2008.01081.x","article-title":"Peyronie's disease intervention trials: methodological challenges and issues","volume":"6","author":"M\u00fcller","year":"2009","journal-title":"J. Sex. Med."},{"issue":"2","key":"10.1016\/j.mcp.2019.101488_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.esxm.2019.01.001","article-title":"Twenty Years of plaque incision and grafting for Peyronie's disease: a review of literature","volume":"7","author":"Rice","year":"2019","journal-title":"Sex. Med."},{"issue":"9","key":"10.1016\/j.mcp.2019.101488_bib25","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/j.1743-6109.2012.02789.x","article-title":"Cryopreserved penile tunica albuginea for allotransplantation: a morphological and ultrastructural investigation","volume":"9","author":"Loreto","year":"2012","journal-title":"J. Sex. Med."},{"issue":"6","key":"10.1016\/j.mcp.2019.101488_bib26","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4103\/1008-682X.192034","article-title":"Microsurgical tunica albuginea transplantation in an animal model","volume":"19","author":"Sansalone","year":"2017","journal-title":"Asian J. Androl."},{"issue":"1","key":"10.1016\/j.mcp.2019.101488_bib27","first-page":"109","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its death receptor (DR5) in Peyronie's disease","volume":"8","author":"Loreto","year":"2011","journal-title":"A biomolecular study of apoptosis activation, J Sex Med"},{"key":"10.1016\/j.mcp.2019.101488_bib28","doi-asserted-by":"crossref","first-page":"616149","DOI":"10.1155\/2014\/616149","article-title":"The role of intrinsic pathway in apoptosis activation and progression in Peyronie's disease,","volume":"2014","author":"Loreto","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"11","key":"10.1016\/j.mcp.2019.101488_bib29","first-page":"1241","article-title":"Increased aquaporin 1 expression in the tunica albuginea of Peyronie's disease patients: an in vivo pilot study","volume":"31","author":"Castorina","year":"2016","journal-title":"Histol. Histopathol."},{"issue":"5","key":"10.1016\/j.mcp.2019.101488_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.ijir.3900874","article-title":"Peyronie's disease cell culture models: phenotypic, genotypic and functional analyses","volume":"14","author":"Mulhall","year":"2002","journal-title":"Int. J. Impot. Res."},{"issue":"11","key":"10.1016\/j.mcp.2019.101488_bib31","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1073\/pnas.93.11.5478","article-title":"Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix","volume":"93","author":"Roth","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.mcp.2019.101488_bib32","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.urology.2007.02.042","article-title":"Intralesional verapamil prevents the progression of Peyronie's disease","volume":"69","author":"Bennett","year":"2007","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.mcp.2019.101488_bib33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0022-5347(05)64691-5","article-title":"Experience with intraplaque injection of verapamil for Peyronie's disease","volume":"168","author":"Levine","year":"2002","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.mcp.2019.101488_bib34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11255-009-9522-4","article-title":"Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study","volume":"41","author":"Shirazi","year":"2009","journal-title":"Int. Urol. Nephrol."},{"issue":"1","key":"10.1016\/j.mcp.2019.101488_bib35","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0022-5347(01)65368-0","article-title":"Scar contracture: cellular and connective tissue aspects in Peyronie's disease","volume":"157","author":"Ehrlich","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/j.mcp.2019.101488_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1743-6109.2007.00651.x","article-title":"The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study","author":"Jordan","year":"2008","journal-title":"J. Sex. Med."},{"issue":"1\u20132","key":"10.1016\/j.mcp.2019.101488_bib37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11010-017-3069-y","article-title":"Exogenous proline stimulates type I collagen and HIF-1\u03b1 expression and the process is attenuated by glutamine in human skin fibroblasts","volume":"435","author":"Szoka","year":"2017","journal-title":"Mol. Cell. Biochem."}],"container-title":["Molecular and Cellular Probes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850819303718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850819303718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:31:08Z","timestamp":1778761868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890850819303718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":37,"alternative-id":["S0890850819303718"],"URL":"https:\/\/doi.org\/10.1016\/j.mcp.2019.101488","relation":{},"ISSN":["0890-8508"],"issn-type":[{"value":"0890-8508","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Verapamil and collagenase differentially affect collagen metabolism in experimental model of Peyronie's disease","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Probes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcp.2019.101488","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101488"}}